S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Avoro Capital Advisors/Q4 2020

Avoro Capital Advisors

Periodo: Q4 2020 Β· Depositato: 2021-02-16
Vedi su SEC EDGAR β†—
AUM
$5.81B
Valore totale del portafoglio
Posizioni
44
Titoli dichiarati
Prima Posizione
MRTX
17.1% $996.1M
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2021-02-16) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
MRTXMIRATI THERAPEUTICS INC$996.1M17.15%β€”β€”
17.1%
HZNPHORIZON THERAPEUTICS PLC$658.4M11.34%β€”β€”
11.3%
UTHRUNITED THERAPEUTICS CORP$432.6M7.45%$151.79$555.91+266.2%
7.5%
IOVAIOVANCE BIOTHERAPEUTICS INC$348.0M5.99%$46.40$4.31-90.7%
6.0%
ARNAARENA PHARMACEUTICALS INC$321.9M5.54%β€”β€”
5.5%
ASNDASCENDIS PHARMA$300.2M5.17%$166.78$274.50+64.6%
5.2%
SRPTSAREPTA THERAPEUTICS INC$298.4M5.14%$170.49$19.28-88.7%
5.1%
ARGXARGENX SE$265.4M4.57%$294.09$939.68+219.5%
4.6%
FOLDAMICUS THERAPEUTICS INC$207.8M3.58%β€”β€”
3.6%
XLRNACCELERON PHARMA INC$198.3M3.42%β€”β€”
3.4%
MRSNMERSANA THERAPEUTICS INC$180.9M3.12%β€”β€”
3.1%
BMRNBIOMARIN PHARMACEUTICAL INC$144.7M2.49%$87.69$58.99-32.7%
2.5%
MDGLMADRIGAL PHARMACEUTICALS INC$136.2M2.35%$111.17$528.10+375.0%
2.4%
KURAKURA ONCOLOGY INC$130.6M2.25%$32.66$11.10-66.0%
2.3%
PMVPPMV PHARMACEUTICALS INC$130.5M2.25%$61.51$1.22-98.0%
2.3%
ACADACADIA PHARMACEUTICALS INC$104.3M1.80%$53.46$25.97-51.4%
1.8%
ADVMADVERUM BIOTECHNOLOGIES INC$86.7M1.49%β€”β€”
1.5%
TRILLIUM THERAPEUTICS INC$85.3M1.47%β€”β€”
1.5%
CNSTCONSTELLATION PHARMACEUTICALS INC$85.0M1.46%β€”β€”
1.5%
DCPHDECIPHERA PHARMACEUTICALS INC$74.2M1.28%β€”β€”
1.3%
PRAXPRAXIS PRECISION MEDICINES INC$68.7M1.18%$825.30$318.52-61.4%
1.2%
CBAYCYMABAY THERAPEUTICS INC$59.1M1.02%β€”β€”
1.0%
ISEEIVERIC BIO INC$50.1M0.86%β€”β€”
0.9%
TVTXTRAVERE THERAPEUTICS INC$49.1M0.85%$27.25$56.92+108.9%
0.8%
RLMDRELMADA THERAPEUTICS INC$48.9M0.84%$32.07$6.28-80.4%
0.8%
XENEXENON PHARMACEUTICALS INC$43.1M0.74%$15.38$60.96+296.4%
0.7%
MRNSMARINUS PHARMACEUTICALS INC$39.4M0.68%β€”β€”
0.7%
OLMAOLEMA PHARMACEUTICALS INC$35.6M0.61%$48.08$12.64-73.7%
0.6%
AMRNXXXXAMARIN CORP PLC$29.3M0.51%β€”β€”
0.5%
AVDLXXXXAVADEL PHARMACEUTICALS PLC$29.2M0.50%β€”β€”
0.5%

AttivitΓ  Trimestre su Trimestre

Q4 2020 vs. Q3 2020

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
UTHRUNITED THERAPEUTICS CORP$432.6M+266.2%
ACADACADIA PHARMACEUTICALS INC$104.3M-51.4%
PRAXPRAXIS PRECISION MEDICINES INC$68.7M-61.4%
TVTXTRAVERE THERAPEUTICS INC$49.1M+108.9%
MRNSMARINUS PHARMACEUTICALS INC$39.4M
OLMAOLEMA PHARMACEUTICALS INC$35.6M-73.7%
MNKDMANNKIND CORP$11.0M
SNDXSYNDAX PHARMACEUTICALS INC$10.0M

Posizioni Chiuse (8)

TickerEmittenteNozionale
IMMUIMMUNOMEDICS INC$2.23B
MYOKMYOKARDIA INC$257.0M
KPTIXXXXKARYOPHARM THERAPEUTICS INC$87.6M
QUREUNIQURE NV$64.5M
MRNSMARINUS PHARMACEUTICALS INC$38.5M
ALTALTIMMUNE INC$26.4M
RTRXRETROPHIN INC$24.5M
RAPTRAPT THERAPEUTICS INC$18.5M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
KURAKURA ONCOLOGY INC$56.0M+64.3%-66.0%
MDGLMADRIGAL PHARMACEUTICALS INC$30.5M+37.6%+375.0%
ARNAARENA PHARMACEUTICALS INC$90.1M+35.2%
PMVPPMV PHARMACEUTICALS INC$73.0M+27.0%-98.0%
HZNPHORIZON THERAPEUTICS PLC$64.1M+17.6%
XLRNACCELERON PHARMA INC$46.4M+14.8%
BDTXBLACK DIAMOND THERAPEUTICS INC$2.3M+6.2%
TRILLIUM THERAPEUTICS INC$7.2M+5.5%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
ATNXATHENEX INC$-35.4M-88.6%
CUECUE BIOPHARMA INC$-22.5M-75.8%
ADAPYADAPTIMMUNE THERAPEUTICS PLC$-68.6M-67.7%
CNSTCONSTELLATION PHARMACEUTICALS INC$-1.6M-31.0%
DCPHDECIPHERA PHARMACEUTICALS INC$-19.2M-28.6%
IOVAIOVANCE BIOTHERAPEUTICS INC$34.1M-21.4%-90.7%
FOLDAMICUS THERAPEUTICS INC$54.6M-17.1%
BMRNBIOMARIN PHARMACEUTICAL INC$11.6M-5.7%-32.7%
← Torna agli Hedge Fund